{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T16:14:57Z","timestamp":1783181697125,"version":"3.54.6"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405224"],"award-info":[{"award-number":["82405224"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009620","name":"Gansu Province Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011783","name":"Gansu Province Department of Finance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011783","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004775","name":"Gansu Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jep.2026.121742","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:07:23Z","timestamp":1777590443000},"page":"121742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dabupi decoction mitigates fluorouracil-induced intestinal mucositis via farnesoid X receptor activation and dihydropyrimidine dehydrogenase upregulation"],"prefix":"10.1016","volume":"367","author":[{"given":"ShunZhi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JunJie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoXia","family":"Wa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuCen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YongQi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2026.121742_bib1","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/jnci\/djt300","article-title":"Human gut microbiome and risk for colorectal cancer","volume":"105","author":"Ahn","year":"2013","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.jep.2026.121742_bib2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1053\/jhep.2000.7877","article-title":"Bile acid synthesis in cultured human hepatocytes: support for an alternative biosynthetic pathway to cholic acid: bile acid synthesis in cultured human hepatocytes: support for an alternative biosynthetic pathway to cholic acid","volume":"31","author":"Axelson","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2026.121742_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jep.2026.121742_bib4","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jep.2026.121742_bib5","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.28600","article-title":"Randomized, open\u2010label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma","volume":"64","author":"Cheng","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2026.121742_bib6","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jep.2026.121742_bib7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jep.2026.121742_bib8","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1038\/cti.2016.17","article-title":"Regulation of immune cell function by short\u2010chain fatty acids","volume":"5","author":"Corr\u00eaa-Oliveira","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.jep.2026.121742_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drup.2015.05.003","article-title":"Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: toward targeted personalized therapy","volume":"20","author":"De Mattia","year":"2015","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.jep.2026.121742_bib10","doi-asserted-by":"crossref","first-page":"vi120","DOI":"10.1093\/annonc\/mdm239","article-title":"Neo-adjuvant and adjuvant chemotherapy of gastric cancer","volume":"18","author":"De Vita","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jep.2026.121742_bib11","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1200\/JCO.18.02309","article-title":"Neoadjuvant modified FOLFOX6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: final results of the Chinese FOWARC trial","volume":"37","author":"Deng","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jep.2026.121742_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile acid nuclear receptor FXR and digestive system diseases","volume":"5","author":"Ding","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jep.2026.121742_bib13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/ijc.25369","article-title":"Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil\/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer","volume":"128","author":"Ducreux","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jep.2026.121742_bib14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jep.2026.121742_bib15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jhep.2010.01.010","article-title":"Regulation of the human bile acid UDP-Glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids","volume":"52","author":"Erichsen","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jep.2026.121742_bib16","series-title":"Protein Complex Prediction with AlphaFold-Multimer","author":"Evans","year":"2021"},{"key":"10.1016\/j.jep.2026.121742_bib18","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1080\/15548627.2021.1872227","article-title":"HIF1A alleviates compression-induced apoptosis of nucleus pulposus derived stem cells via upregulating autophagy","volume":"17","author":"He","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.jep.2026.121742_bib19","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S1470-2045(18)30686-7","article-title":"DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis","volume":"19","author":"Henricks","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jep.2026.121742_bib20","doi-asserted-by":"crossref","first-page":"6040","DOI":"10.1038\/s41467-023-41721-9","article-title":"AlphaFold-Multimer predicts cross-kingdom interactions at the plant-pathogen interface","volume":"14","author":"Homma","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jep.2026.121742_bib21","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jep.2026.121742_bib22","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2014.55.2307","article-title":"Dose-finding and pharmacokinetic study to optimize the dosing of irinotecan according to the UGT1A1 genotype of patients with cancer","volume":"32","author":"Innocenti","year":"2014","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.jep.2026.121742_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid\u2013microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jep.2026.121742_bib24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1158\/1078-0432.CCR-19-1483","article-title":"Clinical assessment of 5-Fluorouracil\/Leucovorin, Nab-paclitaxel, and Irinotecan (FOLFIRABRAX) in untreated patients with gastrointestinal cancer using UGT1A1 genotype\u2013guided dosing","volume":"26","author":"Joshi","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jep.2026.121742_bib25","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1470-2045(21)00027-9","article-title":"Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial","volume":"22","author":"Lamarca","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jep.2026.121742_bib26","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2217\/pgs.14.80","article-title":"Role of solute carrier transporters in pancreatic cancer: a review","volume":"15","author":"Lemstrov\u00e1","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jep.2026.121742_bib27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.annonc.2024.01.002","article-title":"TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes","volume":"35","author":"Loriot","year":"2024","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jep.2026.121742_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbadis.2015.11.001","article-title":"Splenic dendritic cell involvement in FXR-mediated amelioration of DSS colitis","volume":"1862","author":"Massafra","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jep.2026.121742_bib29","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jep.2026.121742_bib30","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1152\/physrev.00058.2017","article-title":"The UDP-glycosyltransferase (UGT) superfamily: new members, new functions, and novel paradigms","volume":"99","author":"Meech","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jep.2026.121742_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108459","article-title":"Drug-drug interactions that alter the exposure of glucuronidated drugs: scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance","volume":"248","author":"Miners","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jep.2026.121742_bib32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ddr.21461","article-title":"Dose translation between laboratory animals and human in preclinical and clinical phases of drug development","volume":"79","author":"Nair","year":"2018","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jep.2026.121742_bib34","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","article-title":"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial","volume":"401","author":"Shitara","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jep.2026.121742_bib35","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1053\/j.gastro.2020.05.067","article-title":"Bile acids signal via TGR5 to activate intestinal stem cells and epithelial regeneration","volume":"159","author":"Sorrentino","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jep.2026.121742_bib36","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1038\/s41467-020-17161-0","article-title":"Mechano-modulatory synthetic niches for liver organoid derivation","volume":"11","author":"Sorrentino","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jep.2026.121742_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100746","article-title":"The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan","volume":"8","author":"Su","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.jep.2026.121742_bib38","doi-asserted-by":"crossref","first-page":"24566","DOI":"10.1002\/anie.202109479","article-title":"A molecular-splicing strategy for constructing a near-infrared fluorescent probe for UDP-glucuronosyltransferase 1A1","volume":"60","author":"Tian","year":"2021","journal-title":"Angew. Chem. Int. Ed Engl."},{"key":"10.1016\/j.jep.2026.121742_bib39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/apt.12878","article-title":"Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications","volume":"40","author":"Touchefeu","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jep.2026.121742_bib40","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the universal protein knowledgebase in 2023","volume":"51","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jep.2026.121742_bib41","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1474-4422(03)00435-6","article-title":"Interactions between antiepileptic and chemotherapeutic drugs","volume":"2","author":"Vecht","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jep.2026.121742_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jep.2026.121742_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40880-019-0349-9","article-title":"The Chinese society of clinical oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer","volume":"39","author":"Wang","year":"2019","journal-title":"Cancer Commun."},{"key":"10.1016\/j.jep.2026.121742_bib44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jama.2020.23370","volume":"325","author":"Wang","year":"2021","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.jep.2026.121742_bib45","first-page":"303","article-title":"Disturbance of bile acids profile aggravates the diarrhea induced by capecitabine through inhibiting the Wnt\/\u03b2-catenin pathway","volume":"S2090\u20131232","author":"Wang","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jep.2026.121742_bib46","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/ijms25031544","article-title":"Bile acid diarrhea: from molecular mechanisms to clinical diagnosis and treatment in the era of precision medicine","volume":"25","author":"Yang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jep.2026.121742_bib47","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/prot.20264","article-title":"Scoring function for automated assessment of protein structure template quality","volume":"57","author":"Zhang","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.jep.2026.121742_bib48","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1200\/JCO.20.01932","article-title":"Multicenter, randomized, phase III trial of neoadjuvant chemoradiation with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer","volume":"38","author":"Zhu","year":"2020","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874126005945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874126005945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:15:03Z","timestamp":1783178103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874126005945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":46,"alternative-id":["S0378874126005945"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2026.121742","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dabupi decoction mitigates fluorouracil-induced intestinal mucositis via farnesoid X receptor activation and dihydropyrimidine dehydrogenase upregulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2026.121742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121742"}}